Healthcare
Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have signed an agreement to establish an oncology center of proton therapy in the Primorsky region. The health clinic shall admit its first patients in 2022, its annual capacity shall be over 1000 patients.
Roswell Park trial identifies small, critical protein involved in anticancer immune response
Last year’s influenza season in the U.S. had record-breaking hospitalization rates. A lot of industry observers are looking at a new flu drug, baloxavir marboxil, for which clinical trial data was just published.
NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy.
Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit on October 4th in Irvine, California.
Changes announced to executive team to accelerate growth and strategy
Vectura regaining momentum with continued inhaled revenue and adjusted EBITDA growth
Biom’up today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director.
Enrolls first clinical trial patients in Sydney, Australia
TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology.
PRESS RELEASES